{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T12:58:46Z","timestamp":1783947526781,"version":"3.55.0"},"reference-count":32,"publisher":"MDPI AG","issue":"21","license":[{"start":{"date-parts":[[2022,11,4]],"date-time":"2022-11-04T00:00:00Z","timestamp":1667520000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"German Ministry of Education and Research (BMBF)","award":["Virtual Liver Project"],"award-info":[{"award-number":["Virtual Liver Project"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cells"],"abstract":"<jats:p>Obesity and obesity-associated diseases represent one of the key health challenges of our time. In this context, aberrant hepatic lipid accumulation is a central pathological aspect of non-alcoholic fatty liver disease (NAFLD). By comparing methylation signatures of liver biopsies before and after bariatric surgery, we recently demonstrated the strong enrichment of differentially methylated heat shock factor 1 (HSF1) binding sites (&gt;400-fold) in the process of liver remodeling, indicating a crucial role of HSF1 in modulating central aspects of NAFLD pathogenesis. Using cellular models of NAFLD, we were able to show that HSF1 is activated during fat accumulation in hepatocytes, mimicking conditions in patients before bariatric surgery. This induction was abolished by starving the cells, mimicking the situation after bariatric surgery. Regarding this connection, carnitine palmitoyltransferase 1 isoform A (CTP1a), a central regulator of lipid beta-oxidation, was identified as a HSF1 target gene by promoter analysis and HSF1 knockdown experiments. Finally, pharmacological activation of HSF1 through celastrol reduced fat accumulation in the cells in a HSF1-dependent manner. In conclusion, we were able to confirm the relevance of HSF1 activity and described a functional HSF1-CPT1a pathway in NAFLD pathogenesis.<\/jats:p>","DOI":"10.3390\/cells11213504","type":"journal-article","created":{"date-parts":[[2022,11,7]],"date-time":"2022-11-07T02:43:51Z","timestamp":1667789031000},"page":"3504","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["The HSF1-CPT1a Pathway Is Differentially Regulated in NAFLD Progression"],"prefix":"10.3390","volume":"11","author":[{"given":"Wiebke","family":"Breternitz","sequence":"first","affiliation":[{"name":"Laboratory of Molecular Gastroenterology & Hepatology, Department of Internal Medicine I, UKSH-Campus Kiel, 24105 Kiel, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Friedrich","family":"Sandk\u00fchler","sequence":"additional","affiliation":[{"name":"Laboratory of Molecular Gastroenterology & Hepatology, Department of Internal Medicine I, UKSH-Campus Kiel, 24105 Kiel, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frauke","family":"Grohmann","sequence":"additional","affiliation":[{"name":"Laboratory of Molecular Gastroenterology & Hepatology, Department of Internal Medicine I, UKSH-Campus Kiel, 24105 Kiel, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jochen","family":"Hampe","sequence":"additional","affiliation":[{"name":"Medical Department 1, University Hospital Dresden, Dresden University of Technology (TU Dresden), 01307 Dresden, Germany"},{"name":"Center for Regenerative Therapies Dresden (CRTD), Dresden University of Technology (TU Dresden), 01307 Dresden, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Brosch","sequence":"additional","affiliation":[{"name":"Medical Department 1, University Hospital Dresden, Dresden University of Technology (TU Dresden), 01307 Dresden, Germany"},{"name":"Center for Regenerative Therapies Dresden (CRTD), Dresden University of Technology (TU Dresden), 01307 Dresden, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Herrmann","sequence":"additional","affiliation":[{"name":"Medical Department 1, University Hospital Dresden, Dresden University of Technology (TU Dresden), 01307 Dresden, Germany"},{"name":"Center for Regenerative Therapies Dresden (CRTD), Dresden University of Technology (TU Dresden), 01307 Dresden, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clemens","family":"Schafmayer","sequence":"additional","affiliation":[{"name":"Department of General, Visceral, Vascular and Transplantation Surgery, University of Rostock, 18057 Rostock, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Meinhardt","sequence":"additional","affiliation":[{"name":"Department for Gastroenterology and Hepatology, University Hospital Oldenburg, Klinikum Oldenburg A\u00f6R, European Medical School (EMS), 26133 Oldenburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Schreiber","sequence":"additional","affiliation":[{"name":"Laboratory of Molecular Gastroenterology & Hepatology, Department of Internal Medicine I, UKSH-Campus Kiel, 24105 Kiel, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6160-1059","authenticated-orcid":false,"given":"Alexander","family":"Arlt","sequence":"additional","affiliation":[{"name":"Department for Gastroenterology and Hepatology, University Hospital Oldenburg, Klinikum Oldenburg A\u00f6R, European Medical School (EMS), 26133 Oldenburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0640-9256","authenticated-orcid":false,"given":"Claudia","family":"Geismann","sequence":"additional","affiliation":[{"name":"Laboratory of Molecular Gastroenterology & Hepatology, Department of Internal Medicine I, UKSH-Campus Kiel, 24105 Kiel, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,11,4]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Zhang, C., and Yang, M. (2021). Current Options and Future Directions for NAFLD and NASH Treatment. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22147571"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"8263","DOI":"10.3748\/wjg.v23.i47.8263","article-title":"Clinical epidemiology and disease burden of nonalcoholic fatty liver disease","volume":"23","author":"Perumpail","year":"2017","journal-title":"World J. Gastroenterol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/j.metabol.2015.12.012","article-title":"The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD)","volume":"65","author":"Buzzetti","year":"2016","journal-title":"Metabolism"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.gastrohep.2017.12.003","article-title":"Consensus document. Management of non-alcoholic fatty liver disease (NAFLD). Clinical practice guideline","volume":"41","author":"Aller","year":"2018","journal-title":"Gastroenterol. Hepatol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.gastrohep.2017.07.006","article-title":"New therapeutic perspectives in non-alcoholic steatohepatitis","volume":"41","author":"Ampuero","year":"2018","journal-title":"Gastroenterol. Hepatol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1053\/j.gastro.2006.03.041","article-title":"NAFLD, obesity, and bariatric surgery","volume":"130","author":"Angulo","year":"2006","journal-title":"Gastroenterology"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1136\/gutjnl-2016-312238","article-title":"Systematic review of bariatric surgery liver biopsies clarifies the natural history of liver disease in patients with severe obesity","volume":"66","author":"Bedossa","year":"2016","journal-title":"Gut"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1002\/hep.28392","article-title":"Diet, weight loss, and liver health in nonalcoholic fatty liver disease: Pathophysiology, evidence, and practice","volume":"63","author":"Marchesini","year":"2016","journal-title":"Hepatology"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1001\/jama.2020.2298","article-title":"Nonalcoholic Steatohepatitis: A Review","volume":"323","author":"Sheka","year":"2020","journal-title":"JAMA"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.cmet.2013.07.004","article-title":"DNA Methylation Analysis in Nonalcoholic Fatty Liver Disease Suggests Distinct Disease-Specific and Remodeling Signatures after Bariatric Surgery","volume":"18","author":"Ahrens","year":"2013","journal-title":"Cell Metab."},{"key":"ref_11","first-page":"4","article-title":"Regulation of heat shock transcription factors and their roles in physiology and disease","volume":"19","author":"Burchfiel","year":"2017","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.metabol.2017.12.001","article-title":"FAM3 gene family: A promising therapeutical target for NAFLD and type 2 diabetes","volume":"81","author":"Zhang","year":"2017","journal-title":"Metabolism"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1002\/hep.29238","article-title":"SIRT1\/HSF1\/HSP pathway is essential for exenatide-alleviated, lipid-induced hepatic endoplasmic reticulum stress","volume":"66","author":"Zheng","year":"2017","journal-title":"Hepatology"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.cmet.2015.08.005","article-title":"Celastrol Protects against Obesity and Metabolic Dysfunction through Activation of a HSF1-PGC1\u03b1 Transcriptional Axis","volume":"22","author":"Ma","year":"2015","journal-title":"Cell Metab."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1046\/j.0022-202x.2001.01612.x","article-title":"Metabolic Fate and Selective Utilization of Major Fatty Acids in Human Sebaceous Gland","volume":"118","author":"Pappas","year":"2002","journal-title":"J. Investig. Dermatol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/hep.20701","article-title":"Design and validation of a histological scoring system for nonalcoholic fatty liver disease","volume":"41","author":"Kleiner","year":"2005","journal-title":"Hepatology"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1038\/nprot.2013.055","article-title":"Imaging of neutral lipids by oil red O for analyzing the metabolic status in health and disease","volume":"8","author":"Mehlem","year":"2013","journal-title":"Nat. Protoc."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"pdb.prot5556","DOI":"10.1101\/pdb.prot5556","article-title":"Labeling nuclear DNA using DAPI","volume":"2011","author":"Chazotte","year":"2011","journal-title":"Cold Spring Harb. Protoc."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Geismann, C., Erhart, W., Grohmann, F., Schreiber, S., Schneider, G., Sch\u00e4fer, H., and Arlt, A. (2018). TRAIL\/NF-kappaB\/CX3CL1 Mediated Onco-Immuno Crosstalk Leading to TRAIL Resistance of Pancreatic Cancer Cell Lines. Int. J. Mol. Sci., 19.","DOI":"10.3390\/ijms19061661"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/j.bbamcr.2017.02.005","article-title":"Role of CCL20 mediated immune cell recruitment in NF-kappaB mediated TRAIL resistance of pancreatic cancer","volume":"1864","author":"Geismann","year":"2017","journal-title":"Biochim. Biophys. Acta Mol. Cell Res."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1080\/15548627.2017.1319544","article-title":"The constitutive lipid droplet protein PLIN2 regulates autophagy in liver","volume":"13","author":"Tsai","year":"2017","journal-title":"Autophagy"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.2337\/db16-0993","article-title":"Hepatic Activation of the FAM3C-HSF1-CaM Pathway Attenuates Hyperglycemia of Obese Diabetic Mice","volume":"66","author":"Chen","year":"2017","journal-title":"Diabetes"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.cmet.2011.03.025","article-title":"Heat Shock Transcription Factor 1 Is a Key Determinant of HCC Development by Regulating Hepatic Steatosis and Metabolic Syndrome","volume":"14","author":"Jin","year":"2011","journal-title":"Cell Metab."},{"key":"ref_24","first-page":"1411","article-title":"A novel HSF1 activator ameliorates non-alcoholic steatohepatitis by stimulating mitochondrial adaptive oxidation","volume":"179","author":"Rao","year":"2022","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"56053","DOI":"10.1074\/jbc.M409267200","article-title":"Celastrols as Inducers of the Heat Shock Response and Cytoprotection","volume":"279","author":"Westerheide","year":"2004","journal-title":"J. Biol. Chem."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1016\/j.chembiol.2011.09.008","article-title":"HSF1-dependent upregulation of Hsp70 by sulfhydryl-reactive inducers of the KEAP1\/NRF2\/ARE pathway","volume":"18","author":"Zhang","year":"2011","journal-title":"Chem Biol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1002\/oby.20919","article-title":"Obesity depresses the anti-inflammatory HSP70 pathway, contributing to NAFLD progression","volume":"23","author":"Porto","year":"2015","journal-title":"Obesity"},{"key":"ref_28","first-page":"E969","article-title":"A moderate increase in carnitine palmitoyltransferase 1a activity is sufficient to substantially reduce hepatic triglyceride levels","volume":"294","author":"Perdomo","year":"2008","journal-title":"Am. J. Physiol. Metab."},{"key":"ref_29","first-page":"821","article-title":"Molecular therapy for obesity and diabetes based on a long-term increase in hepatic fatty-acid oxidation","volume":"53","author":"Herrero","year":"2010","journal-title":"Hepatology"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"11816","DOI":"10.1096\/fj.202000678R","article-title":"Liver CPT1A gene therapy reduces diet-induced hepatic steatosis in mice and highlights potential lipid biomarkers for human NAFLD","volume":"34","author":"Weber","year":"2020","journal-title":"FASEB J."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Lin, C.W., Peng, Y.J., Lin, Y.Y., Mersmann, H.J., and Ding, S.T. (2020). LRRK2 Regulates CPT1A to Promote beta-Oxidation in HepG2 Cells. Molecules, 25.","DOI":"10.3390\/molecules25184122"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.bbagrm.2018.12.009","article-title":"Epigenetic regulation of carnitine palmitoyltransferase 1 (Cpt1a) by high fat diet","volume":"1862","author":"Moody","year":"2018","journal-title":"Biochim. Biophys. Acta (BBA)-Gene Regul. Mech."}],"container-title":["Cells"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2073-4409\/11\/21\/3504\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T01:11:03Z","timestamp":1760145063000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2073-4409\/11\/21\/3504"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,4]]},"references-count":32,"journal-issue":{"issue":"21","published-online":{"date-parts":[[2022,11]]}},"alternative-id":["cells11213504"],"URL":"https:\/\/doi.org\/10.3390\/cells11213504","relation":{},"ISSN":["2073-4409"],"issn-type":[{"value":"2073-4409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,4]]}}}